Highlights Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
1.68 ^USD	-10.16%		-0.59%	-82.87%

22/04	JPMorgan Downgrades Pacific Biosciences of California to Neutral From Overweight	MT
18/04	Scotiabank Adjusts Pacific Biosciences of California's Price Target to $8 From $15, Maintains Sector Outperform Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Higher Late Afternoon	17/04	MT
Sector Update: Health Care	17/04	MT
Pacific Biosciences of California Q1 Revenue Expected to Be Flat Year Over Year; Guidance Lowered; Shares Sink	16/04	MT
Pacific Biosciences of California, Inc. Provides Revenue Guidance for the Second Quarter and Full Year 2024	16/04	CI
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes	27/03	CI
PacBio Announces PureTarget Repeat Expansion Panel, Expanding Its Portfolio of End-To-End Clinical Research Solutions	12/03	CI
Pacific Biosciences of California Q4 Non-GAAP Loss Narrows, Revenue Rises; Shares Drop After Hours	16/02	MT
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q4 Revenue $58.4M, vs. Street Est of $58.3M	16/02	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02	CI
Pacific Biosciences of California, Inc Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale	05/02	CI
PacBio Announces New Nanobind Pandna Kit Enabling Hifi Optimized Dna Extraction Solutions	15/01	CI
Pacific Biosciences Posts Higher Preliminary Q4, Full-Year 2023 Revenue	08/01	MT
PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders	02/11	CI
Pacific Biosciences of California Teams Up With Geneyx, Golden Helix in Disease Research	01/11	MT
PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible	01/11	CI
Pacific Biosciences of California Q3 Loss Narrows, Revenue Gains	31/23/31	MT
Pacific Biosciences of California, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	31/23/31	CI
Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q3 Revenue $55.7M, vs. Street Est of $48.6M	31/23/31	MT
Pacbio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis	11/23/11	CI
Children's Mercy Kansas City First to Use 5-Base HiFi Sequencing from PacBio	06/23/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Pacific Biosciences of California, Inc.

Equities

PACB

US69404D1081

Highlights

Filters